PMID- 37283760 OWN - NLM STAT- MEDLINE DCOM- 20230609 LR - 20230611 IS - 1664-3224 (Electronic) IS - 1664-3224 (Linking) VI - 14 DP - 2023 TI - Socs3 expression in myeloid cells modulates the pathogenesis of dextran sulfate sodium (DSS)-induced colitis. PG - 1163987 LID - 10.3389/fimmu.2023.1163987 [doi] LID - 1163987 AB - INTRODUCTION: Myeloid cells play a critical role in the pathogenesis of Inflammatory Bowel Diseases (IBDs), including Ulcerative Colitis (UC) and Crohn's Disease (CD). Dysregulation of the JAK/STAT pathway is associated with many pathological conditions, including IBD. Suppressors Of Cytokine Signaling (SOCS) are a family of proteins that negatively regulate the JAK/STAT pathway. Our previous studies identified that mice lacking Socs3 in myeloid cells developed a hyper-activated phenotype of macrophages and neutrophils in a pre-clinical model of Multiple Sclerosis. METHODS: To better understand the function of myeloid cell Socs3 in the pathogenesis of colitis, mice with Socs3 deletion in myeloid cells (Socs3 (DeltaLysM)) were utilized in a DSS-induced colitis model. RESULTS: Our results indicate that Socs3 deficiency in myeloid cells leads to more severe colitis induced by DSS, which correlates with increased infiltration of monocytes and neutrophils in the colon and increased numbers of monocytes and neutrophils in the spleen. Furthermore, our results demonstrate that the expression of genes related to the pathogenesis and diagnosis of colitis such as Il1beta, Lcn2, S100a8 and S100a9 were specifically enhanced in Socs3-deficient neutrophils localized to the colon and spleen. Conversely, there were no observable differences in gene expression in Ly6C(+) monocytes. Depletion of neutrophils using a neutralizing antibody to Ly6G significantly improved the disease severity of DSS-induced colitis in Socs3-deficient mice. DISCUSSION: Thus, our results suggest that deficiency of Socs3 in myeloid cells exacerbates DSS-induced colitis and that Socs3 prevents overt activation of the immune system in IBD. This study may provide novel therapeutic strategies to IBD patients with hyperactivated neutrophils. CI - Copyright (c) 2023 Zhou, Yan, Yang, Buckley, Al Diffalha, Benveniste and Qin. FAU - Zhou, Lianna AU - Zhou L AD - Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, United States. FAU - Yan, Zhaoqi AU - Yan Z AD - Gladstone Institute of Neurological Disease, San Francisco, CA, United States. FAU - Yang, Wei AU - Yang W AD - Division of Gastroenterology and Hepatology, Weill Cornell College of Medicine, New York, NY, United States. FAU - Buckley, Jessica A AU - Buckley JA AD - Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, United States. FAU - Al Diffalha, Sameer AU - Al Diffalha S AD - Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States. FAU - Benveniste, Etty N AU - Benveniste EN AD - Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, United States. FAU - Qin, Hongwei AU - Qin H AD - Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, United States. LA - eng GR - R01 NS057563/NS/NINDS NIH HHS/United States GR - R01 CA194414/CA/NCI NIH HHS/United States GR - P30 AR048311/AR/NIAMS NIH HHS/United States GR - P30 AI027767/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20230522 PL - Switzerland TA - Front Immunol JT - Frontiers in immunology JID - 101560960 RN - 9042-14-2 (Dextran Sulfate) RN - EC 2.7.10.2 (Janus Kinases) RN - 0 (STAT Transcription Factors) RN - 0 (Suppressor of Cytokine Signaling Proteins) RN - 0 (Socs3 protein, mouse) RN - 0 (Suppressor of Cytokine Signaling 3 Protein) SB - IM MH - Mice MH - Animals MH - Dextran Sulfate/toxicity MH - Janus Kinases/metabolism MH - Signal Transduction MH - STAT Transcription Factors/metabolism MH - *Colitis MH - Suppressor of Cytokine Signaling Proteins/genetics MH - *Inflammatory Bowel Diseases MH - Myeloid Cells/metabolism MH - Suppressor of Cytokine Signaling 3 Protein/genetics/metabolism PMC - PMC10239850 OTO - NOTNLM OT - inflammatory bowel diseases (IBDs) OT - myeloid cells OT - neutrophils OT - suppressors of cytokine signaling (SOCS) OT - ulcerative colitis (uc) COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/06/07 13:10 MHDA- 2023/06/09 06:42 PMCR- 2023/01/01 CRDT- 2023/06/07 09:37 PHST- 2023/02/11 00:00 [received] PHST- 2023/05/05 00:00 [accepted] PHST- 2023/06/09 06:42 [medline] PHST- 2023/06/07 13:10 [pubmed] PHST- 2023/06/07 09:37 [entrez] PHST- 2023/01/01 00:00 [pmc-release] AID - 10.3389/fimmu.2023.1163987 [doi] PST - epublish SO - Front Immunol. 2023 May 22;14:1163987. doi: 10.3389/fimmu.2023.1163987. eCollection 2023.